S220. BLONANSERIN AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA – WHO IS BENEFITED FROM BLONANSERIN AUGMENTATION? AN OPEN-LABEL, PROSPECTIVE, MULTI-CENTER STUDY

BACKGROUND: Evidences for antipsychotic augmentation for schizophrenic patients with sub-optimal efficacy have been lacking although it has been widespread therapeutic strategy in clinical practice. The purpose of this study was to investigate the efficacy and tolerability of blonanserin augmentatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahk, Won-Myong, Kwon, Young Joon, Yoon, Bo-Hyun, Lee, Sang-Yeol, Lee, Kwanghun, Jon, Duk-In, Kim, Moon Doo, Lim, Eunsung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887360/
http://dx.doi.org/10.1093/schbul/sby018.1007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887360/
http://dx.doi.org/10.1093/schbul/sby018.1007

Ejemplares similares